WO2001098339A3 - Compositions et procedes de traitement et de diagnostic du cancer du sein - Google Patents

Compositions et procedes de traitement et de diagnostic du cancer du sein Download PDF

Info

Publication number
WO2001098339A3
WO2001098339A3 PCT/US2001/019032 US0119032W WO0198339A3 WO 2001098339 A3 WO2001098339 A3 WO 2001098339A3 US 0119032 W US0119032 W US 0119032W WO 0198339 A3 WO0198339 A3 WO 0198339A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
diagnosis
breast cancer
therapy
polypeptides
Prior art date
Application number
PCT/US2001/019032
Other languages
English (en)
Other versions
WO2001098339A2 (fr
Inventor
Steven G Reed
Jiangchun Xu
Davin C Dillon
Marc W Retter
Susan L Harlocker
Original Assignee
Corixa Corp
Steven G Reed
Jiangchun Xu
Davin C Dillon
Marc W Retter
Susan L Harlocker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/602,877 external-priority patent/US6432707B1/en
Application filed by Corixa Corp, Steven G Reed, Jiangchun Xu, Davin C Dillon, Marc W Retter, Susan L Harlocker filed Critical Corixa Corp
Priority to AU2001280443A priority Critical patent/AU2001280443A1/en
Publication of WO2001098339A2 publication Critical patent/WO2001098339A2/fr
Publication of WO2001098339A3 publication Critical patent/WO2001098339A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des compositions et des procédés de traitement et de diagnostic du cancer, notamment le cancer du sein. Les compositions typiques contiennent un ou plusieurs polypeptides de tumeurs du sein, leurs parties immunogènes et des polynucléotides codant pour lesdits polypeptides, une cellule portant un antigène exprimant ces polypeptides, et des cellules T spécifiques de cellules exprimant ces polypeptides. Les compositions de l'invention peuvent, par exemple, servir au diagnostic, à la prévention et/ou au traitement de maladies, notamment le cancer du sein.
PCT/US2001/019032 2000-06-22 2001-06-12 Compositions et procedes de traitement et de diagnostic du cancer du sein WO2001098339A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001280443A AU2001280443A1 (en) 2000-06-22 2001-06-12 Compositions and methods for the therapy and diagnosis of breast cancer

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/602,877 US6432707B1 (en) 1997-12-24 2000-06-22 Compositions and methods for the therapy and diagnosis of breast cancer
US09/602,877 2000-06-22
US68750700A 2000-10-12 2000-10-12
US09/687,507 2000-10-12
US77838101A 2001-02-06 2001-02-06
US09/778,381 2001-02-06

Publications (2)

Publication Number Publication Date
WO2001098339A2 WO2001098339A2 (fr) 2001-12-27
WO2001098339A3 true WO2001098339A3 (fr) 2003-07-31

Family

ID=27416864

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/019032 WO2001098339A2 (fr) 2000-06-22 2001-06-12 Compositions et procedes de traitement et de diagnostic du cancer du sein

Country Status (2)

Country Link
AU (1) AU2001280443A1 (fr)
WO (1) WO2001098339A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1777201A (en) * 1999-11-16 2001-05-30 Eos Biotechnology, Inc. Novel methods of diagnosing and determining prognosis of breast cancer, compositions, and methods of screening for breast cancer modulators
DK2042597T3 (da) * 2000-06-23 2014-08-11 Genentech Inc Sammensætninger og fremgangsmåder til diagnose og behandling af sygdomme, der involverer angiogenese
CN100357320C (zh) * 2005-01-18 2007-12-26 北京大学 Zibc基因及其编码的蛋白和应用
CN100354302C (zh) * 2005-01-18 2007-12-12 北京大学 Sip基因及其编码的蛋白和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018945A1 (fr) * 1996-10-31 1998-05-07 Abbott Laboratories Reactifs et procedes pour le depistage de pathologies mammaires
WO1998021331A1 (fr) * 1996-11-12 1998-05-22 Incyte Pharmaceuticals, Inc. Proteines humaines specifiques de tumeur du sein
WO1998033915A1 (fr) * 1997-02-03 1998-08-06 Human Genome Sciences, Inc. Gene 1 specifique du cancer du sein
WO1999033869A2 (fr) * 1997-12-24 1999-07-08 Corixa Corporation Composes destines a l'immunotherapie et au diagnostic du cancer du sein, et leur mode d'utilisation
WO2001075171A2 (fr) * 2000-04-03 2001-10-11 Corixa Corporation Methodes, compositions et necessaires correspondants servant au depistage et a la surveillance du cancer du sein

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018945A1 (fr) * 1996-10-31 1998-05-07 Abbott Laboratories Reactifs et procedes pour le depistage de pathologies mammaires
WO1998021331A1 (fr) * 1996-11-12 1998-05-22 Incyte Pharmaceuticals, Inc. Proteines humaines specifiques de tumeur du sein
WO1998033915A1 (fr) * 1997-02-03 1998-08-06 Human Genome Sciences, Inc. Gene 1 specifique du cancer du sein
WO1999033869A2 (fr) * 1997-12-24 1999-07-08 Corixa Corporation Composes destines a l'immunotherapie et au diagnostic du cancer du sein, et leur mode d'utilisation
WO2001075171A2 (fr) * 2000-04-03 2001-10-11 Corixa Corporation Methodes, compositions et necessaires correspondants servant au depistage et a la surveillance du cancer du sein

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DIATCHENKO L ET AL: "SUPPRESSION SUBTRACTIVE HYBRIDIZATION: A METHOD FOR GENERATING DIFFERENTIALLY REGULATED OR TISSUE-SPECIFIC CDNA PROBES AND LIBRARIES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, 1 June 1996 (1996-06-01), pages 6025 - 6030, XP002911922, ISSN: 0027-8424 *
JIANG Y ET AL: "DISCOVERY OF DIFFERENTIALLY EXPRESSED GENES IN HUMAN BREAST CANCER USING SUBTRACTED CDNA LIBRARIES AND CDNA MICROARRAYS", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 14, no. 21, 2002, pages 2270 - 2282, XP001075060, ISSN: 0950-9232 *
MARTIN K J ET AL: "A HYBRIDIZATION ARRAY ASSAY USING DIFFERENTIAL DISPLAY-IDENTIFIED MARKERS FOR EARLY DETECTION AND STAGING OF BREAST CANCER", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, NEW YORK, NY, US, vol. 40, 10 April 1999 (1999-04-10), pages 319, XP001026342, ISSN: 0197-016X *
XU ET AL: "Identification of differentially expressed genes in human breast tumor using substraction and microarray", CHEMICAL ABSTRACTS + INDEXES, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 40, March 1999 (1999-03-01), pages 319, XP002160220, ISSN: 0009-2258 *

Also Published As

Publication number Publication date
AU2001280443A1 (en) 2002-01-02
WO2001098339A2 (fr) 2001-12-27

Similar Documents

Publication Publication Date Title
WO2001092581A3 (fr) Compositions et methodes permettant le traitement et le diagnostic du cancer de l'ovaire
WO2001072295A3 (fr) Compositions et methodes pouvant traiter ou diagnostiquer le cancer du poumon
WO2001051633A3 (fr) Compositions et methodes destinees au traitement et au diagnostique du cancer de la prostate
WO2002089747A3 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer de la prostate
WO2001073032A3 (fr) Compositions et methodes de therapie et de diagnostic du cancer de la prostate
WO2002060317A3 (fr) Compositions et methodes pour le traitement et le diagnostic du cancer du pancreas
WO2002074156A8 (fr) Compositions et procedes de therapie et de diagnostic du cancer du colon
WO2004052276A3 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer de la prostate
WO2002016413A3 (fr) Vaccins
WO2002004514A3 (fr) Compositions et procedes pour le traitement et le diagnostic du cancer du poumon
WO2002014503A3 (fr) Compositions et methodes de traitement et de diagnostic de cancers associes a her-2/neu
WO2002092001A3 (fr) Compositions et methodes de traitement et de diagnostic du cancer du poumon
WO2002074237A8 (fr) Compositions et procedes de therapie et de diagnostic du cancer du rein
WO2002012328A3 (fr) Compositions et methodes utilisees dans la therapie et le diagnostic du cancer du colon
WO2002058534A8 (fr) Compositions et methodes pour le traitement et le diagnostic du cancer du colon
WO2003037267A8 (fr) Compositions et methodes de traitement et de diagnostic du cancer des poumons
WO2002078516A3 (fr) Compositions et methodes de traitement et de diagnostic de cancers
WO2001077168A3 (fr) Compositions et procedes permettant de traiter et de diagnostiquer le cancer du poumon
WO2003013431A3 (fr) Compositions et techniques de therapie et de diagnostic du cancer du sein
WO2002012280A3 (fr) Compositions et procedes pour le diagnostic et le traitement du cancer du colon
WO2002039885A3 (fr) Compositions et methodes destinees a la therapie et au diagnostic du cancer de l'ovaire
WO2001090152A3 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer du sein
WO2005051990A3 (fr) Compositions et procedes pour le traitement et le diagnostic du cancer du sein
WO2002000174A3 (fr) Compositions et methodes pour le traitement et le diagnostic du cancer du poumon
WO2003086175A3 (fr) Compositions et procedes destines au traitement et au diagnostic du cancer du poumon

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP